CRON - クロノス・グル―プ (Cronos Group Inc.) クロノス・グル―プ

 CRONのチャート


 CRONの企業情報

symbol CRON
会社名 Cronos Group Inc (クロノス・グル―プ)
分野(sector) Consumer Durables   耐久消費財
産業(industry) Specialty Chemicals  
業種    医療関連(Health Care)
概要 事業概要 --   クロノス・グル―プはカナダの医療用大麻事業会社。医療目的大麻規制(MMPR)に基づき、カナダ保健省が発行した医療用大麻生産ライセンスを所有または申請する企業への投資を中心に事業を行う。また、子会社を通じ、大麻油の栽培や医療用大麻の生産および販売にも従事する。本社所在地はトロント。   
本社所在地 720 King Street West Suite 320 Toronto Ontario M5V 2T3 CAN
代表者氏名
代表者役職名
電話番号
設立年月日 41122
市場名 NASDAQ National Market System
ipoyear ―年
従業員数
url
nasdaq_url https://www.nasdaq.com/symbol/cron
adr_tso
EBITDA EBITDA ー
終値(lastsale) 9.6933
時価総額(marketcap) 1714799401.4388
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 CRONのテクニカル分析


 CRONのニュース

   Cronos Group Encourages Responsibility In Cannabis Industry, Introduces Marketing Code  2021/05/10 16:15:47 Benzinga
Cronos Group Inc. (NASDAQ: CRON ) (TSX: CRON) released a Marketing Code addressing the issue of targeting young people who are below the legal age for adult-use cannabis consumption. Kurt Schmidt, President and CEO of the Toronto-based Cronos Group, emphasized a need for standards and principles that will elevate industry practices. To that end Cronos plans to promote the following principles: Advertising will be directed … Full story available on Benzinga.com
   Cronos Q1 Earnings Impacted By COVID-19 Related Restrictions  2021/05/07 14:32:10 Benzinga
Cronos Group Inc (NASDAQ: CRON ) reported a Q1 adjusted EBITDA loss of $37.07 million, marginally up from $37.05 million reported a year ago. This slight increase in losses was primarily driven by the rise in sales and marketing costs due to … Full story available on Benzinga.com
   Earnings Scheduled For May 7, 2021  2021/05/07 08:12:39 Benzinga
Companies Reporting Before The Bell • Cronos … Full story available on Benzinga.com
   Expected Moves: Draftkings, Square, Roku, AMC, Peloton, Moderna, Rocket, Uber, Cronos And More  2021/05/03 14:34:10 Benzinga
The Broader Markets Last Week – SPY closed slightly higher on the week but below its intra-week highs. The VIX closed higher on the week, up to 18.60 from 17. This Week – SPY options are pricing a 1.2% move (in either direction) for the upcoming week. That corresponds to about $412 as a bearish consensus and $422 as a bullish consensus . Expected Moves for This Week via Options AI : SPY 1.1% QQQ 1.6% IWM 2.2% QQQ vol (and expected move) is slightly less than last week with the earnings reports from Apple (NASDAQ: AAPL ), Facebook (NASDAQ: FB ), Amazon (NASDAQ: AMZN ), Microsoft (NASDAQ: MSFT ) and Alphabet (NASDAQ: GOOGL ) now out of the way. Options AI provides a free expected move calculator that allows you to compare expected moves on the same chart. Expected Moves For Companies Reporting Earnings Following one of the biggest weeks of the earnings season that saw much of FAANG report, this week sees some smaller cap in the news stocks like Draftkings (NASDAQ: DKNG ), Moderna (NASDAQ: MRNA ), AMC (NYSE: AMC ), Viacom (NASDAQ: VIAC ) and Rocket (NASDAQ: …
   The CEO of cannabis giant Aurora explains why he's laser focused on plant genetics and predicts a 'Monsanto' of cannabis will emerge  2021/05/03 12:30:00 Business Insider
Summary List Placement Aurora Cannabis CEO Miguel Martin thinks the cannabis industry , and those who pay close attention to it, aren't talking enough about the value of plant genetics. "There's going to be a cannabis company that looks more like Monsanto," Martin said in an interview with Insider, referring to the agricultural and chemical company best known for genetically modified crops. Aurora is the second-biggest cannabis company by market cap in the world. By that, he means companies that want to dominate the emerging industry will need to create cannabis strains with specific genetic profiles that give users the desired taste, smell, and psychoactive effects — and be sure that the product can be replicated consistently across different markets. These types of products can command higher prices on the dispensary shelf, and offer producers higher margins as well, analysts say. Monsanto was the subject of a lot of criticism for its role in the proliferation of genetically modified crops — some of it fair, some not so much.
   Cronos Group Inc. to Hold 2020 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2021 | MarketScreener  2021/02/12 14:00:08 MarketScreener
TORONTO, Feb. 12, 2021 -- Cronos Group Inc. will hold its 2020 Fourth Quarter and Full-year Earnings Conference Call on Friday, February 26, 2021 at 8:30 a.m. EST. Cronos Group’s… | February 12, 2021
   Cronos Group Inc. to Hold 2020 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2021  2021/02/12 14:00:00 GlobeNewswire
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Fourth…
   Cronos Group Inc. stock outperforms competitors despite losses on the day  2021/02/11 22:04:00 MarketWatch
Shares of Cronos Group Inc. plummeted 21.86% to $12.15 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the…
   Cannabis Stock Squeeze: Option Traders Eyeing New Highs For Tilray (TLRY)  2021/02/10 20:59:41 Benzinga
With cannabis stocks in the news this week, we’ll reveal what the options market is expecting in terms of upcoming stock moves and look at how options can play a role in potential short-squeeze situations. Using Tilray, Inc. (NASDAQ: TLRY ) as an example, we’ll also look at how spreads might be used in a high-premium environment to reduce capital outlay – whatever your trading view. Overview and Expected Moves First, a comparison of some of the expected moves over the next month for Tilray, Canopy Growth Corporation (NASDAQ: CGC ), Aurora Cannabis Inc. (NYSE: ACB ), Aphria Inc. (NASDAQ: APHA ) and Cronos Group Inc. (NASDAQ: CRON ) via the Options AI Calculator With Tilray (TLRY) trading about $55, the options market is pricing an expected move for the month of over 60% in either direction. (note – the company is set to report earnings the first week of March). The move being priced in options corresponds to about $90 for a bullish consensus and $20 bearish: Short Squeezes and Option Strikes At the time of writing, the highest near-dated option strike is 65.
   Cronos Group Is Showing Us a Bullish Picture  2021/02/09 20:00:00 The Street RealMoney
Traders should look to buy available weakness into the $12-$11 area….CRON
   $CRON #CRONOSINC - Mixed Equities As Feds Stands Still  2020/12/17 14:30:09 CentralCharts
STATE OF THE MARKETS Mixed equities as Feds stands still. US equities finished mixed Wednesday, with Dow fell 45 points (-0.2%), S&P500 edged 7 points higher (+0.2%) and Nasdaq climbed 63 points (+0.5%) when the Federal Reserve kept its rate unchanged and vowed to support the economy until full employment is restored. Treasury yields moved higher on the news, with the 10Y benchmark reached as high as 0.96% before settled at 0.92%. Crude continued its upward trajectory, to close above $47.80, running through all stops around $48.00/20 when EIA reported that US crude inventories was reduced by 3.1m barrels last Friday. Similarly, gold advanced higher, closing above $1864.10, as inflation become primary concern for 2021. In the FX space, Dollar seemed supported by CAD in the short and medium term, albeit temporarily on year end profit taking. Yen retained lead in demand against the commodity CAD in all three horizons as CBOE put/call ratio increased, which signaled more safe-haven demand as evident in more inflows to bond than stocks.
   The men who engineered the biggest merger in cannabis lay out why the $4 billion tie-up makes the new Tilray an enticing target for a strategic partner  2020/12/16 21:45:40 Business Insider
Summary List Placement Canadian cannabis producers Tilray and Aphria are merging in a blockbuster deal that would give the combined firm a near $4 billion valuation and make it the world's largest cannabis company by revenue, the companies announced on Wednesday morning. Aphria CEO Irwin Simon and Tilray CEO Brendan Kennedy said in a Wednesday morning interview with Business Insider that the merger would be a boon to shareholders of both companies and that it would give the combined company an effective platform to take advantage of the potentially $100 billion US cannabis market . Aphria agreed in November to acquire the US brewer SweetWater Brewing Company and Tilray owns a US CBD business, Manitoba Harvest. On top of that, it would also make the combined company an attractive target for a large strategic partner, like beer giant Constellation Brands' investment into cannabis rival Canopy Growth, or Altria's investment into Cronos Group. Sending a message to potential partners "A number of large strategic investors in the US, and a number of large strategic investors globally have been waiting to identify who are going to be the consolidators or what companies are going to consolidate the industry," Kennedy told BI. "I think Irwin and I sent a message today with this combination," Kennedy said.
   Cannabis Stocks Watchlist: Canopy Growth Falls After Closures  2020/12/13 16:00:00 The Street
See how cannabis stocks such as GW Pharmaceuticals, Canopy Growth and Cronos Group performed in the market this week.
   Cannabis Stocks Spotlight: Canopy Growth vs. Cronos Group  2020/12/08 12:55:07 Schaeffers Investment Research
A comparison of the technicals and fundamentals behind CGC and CRON
   Cannabis Industry Launches Unique Vape Recycling Program, Partners with Leading Recycler  2020/12/01 14:00:00 Cision (Canada)
/CNW/ - Leading Canadian cannabis companies – 48North, Aurora Cannabis, Aphria Inc., Canopy Growth, Cronos Group – and the Cannabis Council of Canada ('C3'),…

 関連キーワード  (― 米国株 クロノス・グル―プ CRON Cronos Group Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)